ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

FDA advisers endorse gene therapy to treat form of blindness – The Daily Herald

FDA advisers endorse gene therapy to treat form of blindnessThe Daily HeraldSILVER SPRING, Md. — A potentially groundbreaking treatment for a rare form of blindness moved one step closer to U.S. approval Thursday, as federal health advisers endorsed th… Continue reading

2017-10-13 Michael Zand NEWS

FDA advisers urge approval for first gene therapy for inherited … – Washington Post

Continue reading

2017-10-12 Michael Zand NEWS

Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating … – Dove Medical Press

Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating …Dove Medical PressBackground: Silver nanoparticles (AgNPs) exhibit strong antibacterial and anticancer activity owing to their large surface-to-… Continue reading

2017-10-12 Michael Zand NEWS

Allergy Immunotherapy Market Trends, Size, Growth, Opportunities and 2021 Forecast Report Available at … – Markets Insider

Allergy Immunotherapy Market Trends, Size, Growth, Opportunities and 2021 Forecast Report Available at …Markets InsiderPUNE, India, Oct. 12, 2017 /PRNewswire-iReach/ — This latest report titled "Global Allergy Immunotherapy Market (2017-2021 Ed… Continue reading

2017-10-12 Michael Zand NEWS

Allergy Immunotherapy Market Trends, Size, Growth, Opportunities and 2021 Forecast Report Available at … – Markets Insider

Allergy Immunotherapy Market Trends, Size, Growth, Opportunities and 2021 Forecast Report Available at …Markets InsiderPUNE, India, Oct. 12, 2017 /PRNewswire-iReach/ — This latest report titled "Global Allergy Immunotherapy Market (2017-2021 Ed… Continue reading

2017-10-12 Michael Zand NEWS

Immunotherapy Continues to Excite in NSCLC – OncLive

Immunotherapy Continues to Excite in NSCLCOncLiveFeldman: I was asked to speak on first- and second-line immunotherapy in lung cancer, as well as third-line and beyond. I reviewed the various trials that led to the FDA approval of first-line therapy, s… Continue reading

2017-10-12 Michael Zand NEWS

FDA Panel Advises Approval of Gene Therapy for Blinding Disease – NBCNews.com


Washington Post

FDA advisers urge approval for first gene therapy for inherited …
Washington Post
A Food and Drug Administration advisory committee unanimously endorsed an experimental gene therapy Thursday for patients with a rare kind of hereditary …
FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review
FDA Panel Advises Approval of Gene Therapy for Blinding DiseaseNBCNews.com
FDA advisers back gene therapy for rare form of blindnessNature.com
FierceBiotech –The Lancet –New England Journal of Medicine –Perelman School of Medicine – University of Pennsylvania
all 172 news articles »
Continue reading

2017-10-12 Michael Zand NEWS

FDA advisers back gene therapy for rare form of blindness – Nature.com


NBCNews.com

FDA Panel Advises Approval of Gene Therapy for Blinding Disease
NBCNews.com
Misty Lovelace of Alexandria, Kentucky, had never clearly seen her mother’s face. She’d never seen stars. But all that changed when the 18-year-old got an experimental gene therapy treatment that not only stopped her from going blind, but gave her back …
FDA advisers urge approval for first gene therapy for inherited diseaseWashington Post
FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review
Accessibility linksNPR
Futurism –Newsweek –Barron’s
all 47 news articles »
Continue reading

2017-10-12 Michael Zand NEWS
  • 1
  • …
  • 1,057
  • 1,058
  • 1,059
  • 1,060
  • 1,061
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Nature.com

FDA advisers back gene therapy for rare form of blindness
Nature.com
Advisers to the US Food and Drug Administration (FDA) have paved the way for the agency’s first approval of a gene therapy to treat a disease caused by a genetic mutation. On 12 October, a panel of external experts unanimously voted that the benefits …
FDA advisers urge approval for first gene therapy for inherited diseaseWashington Post
FDA Panel Advises Approval of Gene Therapy for Blinding DiseaseNBCNews.com
FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review
Science Magazine –New England Journal of Medicine –The Lancet –OHSU
all 172 news articles »